Olimel N9

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N9, is a mixture of essential and non‑essential amino acids presented as a powder for oral use. It is intended to support metabolic functions and protein synthesis in patients requiring nutritional supplementation.

GNH USA supplies Olimel N9 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Olimel N9 provides amino acid supplementation that supports several metabolic and clinical situations: - Protein‑energy malnutrition: helps restore nitrogen balance and lean body mass. - Post‑surgical recovery: aids tissue repair and wound healing. - Chronic kidney disease (conservative management): supplies essential amino acids while limiting nitrogen load. - Oncology supportive care: contributes to maintaining muscle mass during chemotherapy. - Critical illness/ICU support: assists in meeting increased protein requirements. - Pediatric growth support: provides building blocks for normal growth in children with malabsorption.

Amino acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Vomiting: occasional episodes, especially if taken on an empty stomach. - Diarrhea: loose stools may appear during initial administration. - Abdominal cramps: transient cramping reported by some patients. - Metallic taste: a transient metallic sensation in the mouth. - Headache: mild headache reported in a minority of users.

Serious or Rare Side Effects: - Hyperammonemia: elevated blood ammonia levels in patients with severe liver dysfunction. - Allergic reaction: rash, itching, or urticaria indicating hypersensitivity. - Anaphylaxis: rare but potentially life‑threatening systemic reaction. - Metabolic acidosis: rare disturbance of acid‑base balance. - Renal impairment worsening: excessive amino acid load may aggravate pre‑existing kidney disease. - Electrolyte imbalance: rare disturbances in potassium or sodium levels.

When using Olimel N9, consider the following safety measures: - Renal function assessment: evaluate kidney performance before initiating therapy. - Liver function monitoring: check hepatic enzymes in patients with known liver disease. - Gastrointestinal tolerance: start with a low dose and increase gradually to improve tolerance. - Nutritional status review: ensure the product fits within the overall dietary plan. - Drug‑interaction review: verify compatibility with concurrent medications. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Amino acid preparations can influence the absorption or metabolism of certain drugs.

Major Interactions (Avoid): - Levodopa: may reduce the efficacy of levodopa therapy in Parkinson's disease. - Anticonvulsants: high‑dose amino acids can alter plasma levels of some anticonvulsants. - Thyroid hormones: may interfere with absorption of levothyroxine.

Moderate Interactions (Monitor Closely): - Insulin: amino acids can affect glucose metabolism, requiring dose adjustments. - Diuretics: may increase risk of electrolyte disturbances. - Antibiotics (e.g., tetracyclines): oral amino acids can bind and reduce antibiotic absorption.